Predictors of In-Hospital and G-Month Outcome After Acute Myocarclial Infarction in the Reperfusion Era: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial ad-Large randomized placebo-controlled trials of thrombolytic therapy in patients with evolving acute myocardial infarction

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Does Thrombolysis in Myocardial Infarction (T1MM) Perfusion Grade 2 Represent a Mostly Patent Artery or a -Mostly Occielded Artery? Enzymatic and Electrocardiograpnic Evidence From the TEAM-2 Study

  2016cited by this paper
• Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry).

  1994cited by this paper
• Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.

  1993cited by this paper
• Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

  1993cited by this paper
• A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

  1993cited by this paper
• A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

  1993cited by this paper
• The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

  1993cited by this paper
• Predictors of Early Morbidity and Mortality After Thrombolytic Therapy of Acute Myocardial Infarction: Analyses of Patient Subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase II

  1992cited by this paper
• ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

  1992cited by this paper
• Direct Angioplasty for Acute Myocardial Infarction

  1992cited by this paper
• Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?

  1992cited by this paper
• Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial

  1991cited by this paper
• Diagnostic testing in acute myocardial infarction: does patient age influence utilization patterns? The Worcester Heart Attack Study.

  1991cited by this paper
• Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy.

  1991cited by this paper
• Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.

  1990cited by this paper
• Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator.

  1990cited by this paper
• The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

  1989cited by this paper
• Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues.

  1988cited by this paper
• Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction.

  1988cited by this paper
• Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction.

  1988cited by this paper
• Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials.

  1988cited by this paper
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)

  1988cited by this paper
• EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL

  1988cited by this paper
• Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients.

  1988cited by this paper
• A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

  1987cited by this paper
• A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity.

  1987cited by this paper
• Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study.

  1987cited by this paper
• Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage.

  1987cited by this paper
• EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

  1986cited by this paper
• Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival.

  1986cited by this paper
• Ventricular arrhythmias initiated by programmed stimulation in four groups of patients with healed myocardial infarction.

  1986cited by this paper
• A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction.

  1986cited by this paper
• Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction.

  1986cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report.

  1985cited by this paper

• No citing papers are available for this paper.